These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38053615)

  • 1. Real-world effectiveness and persistence of secukinumab in the treatment of patients with psoriatic arthritis.
    Alegre-Sancho JJ; Núñez-Monje V; Campos-Fernández C; Balaguer-Trull I; Robustillo-Villarino M; Aguilar-Zamora M; Garijo-Bufort M; Pedraz-Penalva T; Peña-González C; de la Morena I; Bedoya-Sanchís D; Yankova-Komsalova L; Conesa-Mateos A; Martinez-Cristóbal A; Navarro-Blasco FJ; Senabre-Gallego JM; Sivera F
    Front Med (Lausanne); 2023; 10():1294247. PubMed ID: 38053615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-world experience with secukinumab in the entire axial spondyloarthritis spectrum.
    Sivera F; Núñez-Monje V; Campos-Fernández C; Balaguer-Trull I; Robustillo-Villarino M; Aguilar-Zamora M; Garijo-Bufort M; López-Gómez JM; Peña-González C; de la Morena I; Bedoya-Sanchís D; Yankova-Komsalova L; Conesa-Mateos A; Martínez-Cristóbal A; Navarro-Blasco FJ; Senabre-Gallego JM; Alegre-Sancho JJ
    Front Med (Lausanne); 2023; 10():1156557. PubMed ID: 37250652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-World Persistence and Treatment Patterns in Patients with Psoriatic Arthritis Treated with Anti-IL17 Therapy in Spain: The PerfIL-17 Study.
    Joven B; Manteca CF; Rubio E; Raya E; Pérez A; Hernández R; Manrique S; Núñez M; Díaz-Cerezo S; Moyano S; Lacetera A; García-Vicuña R
    Adv Ther; 2023 Dec; 40(12):5415-5431. PubMed ID: 37804475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-World Effectiveness and Treatment Retention of Secukinumab in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: A Descriptive Observational Analysis of the Spanish BIOBADASER Registry.
    Moreno-Ramos MJ; Sanchez-Piedra C; Martínez-González O; Rodríguez-Lozano C; Pérez-Garcia C; Freire M; Campos C; Cáliz-Caliz R; Calvo J; Blanco-Madrigal JM; Pérez-Gómez A; Moreno-Martínez MJ; Linares L; Sánchez-Alonso F; Sastré C; Castrejón I
    Rheumatol Ther; 2022 Aug; 9(4):1031-1047. PubMed ID: 35467242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of 6-month Use of Secukinumab in Patients With Psoriatic Arthritis in the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.
    Mease PJ; Blachley T; Dube B; McLean RR; Kim N; Hur P; Ogdie A
    J Rheumatol; 2022 Jul; 49(7):700-706. PubMed ID: 35428716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of Tofacitinib in Patients Initiating Therapy for Psoriatic Arthritis: Results from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.
    Mease PJ; Young P; Fallon L; Mundayat R; Dina O; Blachley T; Middaugh N; Ogdie A
    Rheumatol Ther; 2024 Apr; 11(2):313-329. PubMed ID: 38252211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canadian Adalimumab Postmarketing Observational Epidemiological Study Assessing Effectiveness in Psoriatic Arthritis (COMPLETE-PsA): 12-month Results of Comparative Effectiveness of Adalimumab and nbDMARDs.
    Khraishi MM; Remple VP; Silverberg S; Stewart JC; Florica B; Bessette L
    J Rheumatol; 2022 May; 49(5):454-464. PubMed ID: 35033999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-World Retention and Clinical Effectiveness of Secukinumab for Psoriatic Arthritis: Results From the Canadian Spondyloarthritis Research Network.
    Gladman DD; Choquette D; Khraishi M; Inman RD; Hussein S; Neish D; Leclerc P
    J Rheumatol; 2023 May; 50(5):641-648. PubMed ID: 36521913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a 52-week real-life study in an Italian cohort.
    Molica Colella F; Zizzo G; Parrino V; Filosa MT; Cavaliere R; Fazio F; Molica Colella AB; Mazzone A
    Adv Rheumatol; 2023 Mar; 63(1):15. PubMed ID: 36973825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of pre-existing radiographic damage and its relationship with joint activity and long-term clinical outcomes with secukinumab therapy in patients with psoriatic arthritis.
    Mease P; van der Heijde D; Kirkham B; Schett G; Orbai AM; Ritchlin C; Merola JF; Pricop L; James DA; Zhu X; Ligozio G
    Arthritis Res Ther; 2022 Dec; 24(1):283. PubMed ID: 36578042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of one-year treat-to-target strategy in early psoriatic arthritis: data of an open-label REMARCA study.
    Korotaeva TV; Loginova EY; Getiya TS; Nasonov EL
    Ter Arkh; 2018 May; 90(5):22-29. PubMed ID: 30701886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secukinumab Efficacy on Psoriatic Arthritis GRAPPA-OMERACT Core Domains in Patients with or Without Prior Tumor Necrosis Factor Inhibitor Use: Pooled Analysis of Four Phase 3 Studies.
    Orbai AM; Husni ME; Gladman DD; Leung YY; Siebert S; Tillett W; Vis M; Chambenoit O; Meng X; Mease PJ
    Rheumatol Ther; 2021 Sep; 8(3):1223-1240. PubMed ID: 34218429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secukinumab as Biological Treatment for Psoriatic Arthritis in Real Clinical Practice.
    Pinto Tasende JA; Maceiras Pan FJ; Mosquera Martínez JA; Fernández Dominguez L; Correa Rey B; García Porrúa C
    Reumatol Clin (Engl Ed); 2021 Apr; 17(4):203-206. PubMed ID: 31492601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of TNF-α inhibition
    Elliott A; Wright G; Pendleton A; Rooney M
    Ther Adv Musculoskelet Dis; 2023; 15():1759720X231179524. PubMed ID: 38024204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ixekizumab therapy following secukinumab inadequate response in psoriatic arthritis: a case series focusing on axial disease.
    Panagiotopoulos A; Koutsianas C; Kougkas N; Moschou D; Bournia VK; Gazi S; Tektonidou MG; Vassilopoulos D; Sfikakis PP; Fragoulis GE
    Rheumatol Int; 2023 May; 43(5):969-973. PubMed ID: 36840819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real world effectiveness and satisfaction with secukinumab in the treatment of patients with psoriatic arthritis: a population survey in five European countries.
    Conaghan PG; Keininger DL; Holdsworth EA; Booth N; Modi NN; Tian H; Kiltz U
    Curr Med Res Opin; 2021 Oct; 37(10):1845-1853. PubMed ID: 34256669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secukinumab efficacy on resolution of enthesitis in psoriatic arthritis: pooled analysis of two phase 3 studies.
    Coates LC; Wallman JK; McGonagle D; Schett GA; McInnes IB; Mease PJ; Rasouliyan L; Quebe-Fehling E; Asquith DL; Fasth AER; Pricop L; Gaillez C
    Arthritis Res Ther; 2019 Dec; 21(1):266. PubMed ID: 31801620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and safety of secukinumab in 608 patients with psoriatic arthritis in real life: a 24-month prospective, multicentre study.
    Ramonda R; Lorenzin M; Carriero A; Chimenti MS; Scarpa R; Marchesoni A; Lubrano di Scorpaniello E; Salvarani C; Cauli A; Semeraro A; Santo L; Ortolan A; Doria A; Fracassi E; Virelli G; Masia M; Fanizzi R; Visalli E; Amato G; Carletto A; Foti R;
    RMD Open; 2021 Feb; 7(1):. PubMed ID: 33593933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Six-Month Persistence and Multi-domain Effectiveness of Guselkumab in Adults with Psoriatic Arthritis: Real-World Data from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.
    Mease PJ; Ogdie A; Tesser J; Shiff NJ; Lin I; Chakravarty SD; Kelleman M; Dodge R; McLean RR; Broadwell A; Kavanaugh A; Merola JF
    Rheumatol Ther; 2023 Dec; 10(6):1479-1501. PubMed ID: 37597159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Secukinumab on the Different GRAPPA-OMERACT Core Domains in Psoriatic Arthritis: A Pooled Analysis of 2049 Patients.
    Orbai AM; McInnes IB; Coates LC; Husni ME; Gladman DD; Gossec L; Pricop L; Chambenoit O; Meng X; Mease PJ
    J Rheumatol; 2020 Jun; 47(6):854-864. PubMed ID: 31615919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.